Founder Radar · PAST 24 HOURS

Dev tools design launches lead a 22-signal day; India funding shifts toward deep tech (semiconductors, biotech, EV infra) over fintech.

India's funding window widened beyond fintech into capital-intensive verticals: Stable Money (₹25M Series C), Statiq (₹18M growth for EV charging), Vervesemi (₹10M Series A semiconductors), Peptris (₹7.7M Series A biotech). Globally, constraint-based design tools and container/runtime infra continue to draw launch interest from developer-first audiences.

22 Signals
$60.7M Funding
5 Patterns

Wednesday, February 18, 2026 · See today's →

Patterns That Formed

Dev Tools Design

EMERGING
2 LAUNCHESOSSGLOBAL

Q12 and VectorNest launched as open-source constraint-based design tools targeting mechanical engineers and product designers. Neither has secured funding yet; both rely on freemium SaaS or open-source distribution. Gap: no funded play yet in constraint solving for design automation—ripe for early-stage venture.

7-day momentum

Fintech Wealth

EMERGING
1 ROUNDSAASINDIA

Stable Money closed a ₹25M Series C led by Peak XV to expand its product portfolio across wealth management segments. This marks India's mature fintech wave—later-stage consolidation rather than new problem discovery. Underserved edge: portfolio allocation for tier-2 investors remains friction-heavy.

7-day momentum

Climate Carbon

EMERGING
1 ROUNDINDIA

Infra Startup Statiq raised ₹18M growth funding from Tenacity Ventures to scale EV charging network infrastructure. India's energy transition now attracts large cheques; Statiq's growth round signals operator confidence in unit economics. Gap: last-mile charging logistics and rural grid integration remain under-capitalized.

7-day momentum

Semiconductor Hardware

EMERGING
1 ROUNDINDIA

Vervesemi closed ₹10M Series A from angel Ashish Kacholia to commercialize semiconductor IP. India's chip design wave accelerates; Vervesemi targets product-stage scaling. Gap: manufacturing partnerships and fab access remain gatekeepers—fabless plays proliferate but foundry capex is concentrated.

7-day momentum

Biotech Pharma

EMERGING
1 ROUNDINDIA

Peptris raised ₹7.7M Series A from IAN Alpha Fund to scale AI-led drug discovery. Preclinical automation via ML is attracting early-stage capital; Peptris targets molecule screening acceleration. Gap: clinical trial data standardization and regulatory pathway clarity remain fragmented across geographies.

7-day momentum

$7.7M

Explore →

India Watch

· Past 24 hours

India's 24h funding mix shifted decisively toward deep tech: Stable Money (fintech, ₹25M), Statiq (EV infra, ₹18M), Vervesemi (semiconductors, ₹10M), Peptris (biotech, ₹7.7M). Total ₹60.7M across four verticals signals a maturing ecosystem moving past SaaS/fintech into capex-heavy, long-cycle infrastructure and hard tech.

Get the weekly deep dive in your inbox

Every Sunday, we go three levels deep on the strongest pattern of the week — competitive density, pricing benchmarks, and the underserved edge.

No spam. Unsubscribe anytime. One email a week.

Recent Days